Analyst recommendations: Cigna, EasyJet, Facebook, Lululemon, Walt Disney...
Citing 'impressive' quarterly results, Wedbush raised Lululemon's price target. Cowen initiates coverage on many stocks. British airline Easyjet announced that it had recently been the subject of an unsolicited takeover bid but said it had rejected it. It also proceeded to a capital increase of 1.2 billion pounds, and get a lower target price from Barclays to reflect these changes. Meanwhile, Devon energy got ejected from Goldman Sachs' "conviction-buy" list.
- Alignment Healthcare : Cowen initiates coverage with outperform rating, $24 price target
- Amedisys : Cowen initiates with market perform rating, $195 price target
- Bright Health : Cowen starts coverage with outperform rating, $14 price target
- Cigna : Cowen downgrades to market perform from outperform, sets $235 price target
- Colfax: Goldman Sachs downgrades to neutral from buy. PT up 8.7% to $51
- Dada Nexus : Goldman Sachs adjusts price target for dada nexus to $42 from $46, maintains buy rating
- Devon Energy : Goldman Sachs removes Devon Energy from Conviction-Buy List, maintains Buy rating
- EasyJet: Barclays remains Neutral. The target price is now set at GBp 685 as compared to GBp 940 previously.
- Facebook : HSBC adjusts price target to $300 from $275, maintains reduce rating
- Global Payments : Morgan Stanley adjusts price target to $185 from $219, maintains equal-weight rating
- Humana : Cowen upgrades to outperform from market perform, sets $479 price target
- Intapp : Credit Suisse adjusts price target to $45 from $38, keeps outperform rating
- International Consolidated Airlines Group: Credit Suisse is positive on the stock with a Buy rating. The target price is reduced from GBp 256 to GBp 195.
- Iveric bio: Stifel initiated coverage of Iveric bio Inc. with a recommendation of buy. PT set to $22
- LHC : Cowen starts coverage with Outperform rating, $209 Price Target
- LifeStance Health : Cowen initiates coverage with Outperform rating, $18 Price Target
- Lululemon Athletica : Wedbush hikes price target to $340 from $300
- Sunrun : Needham initiates coverage with buy rating
- Walt Disney : Wolfe Research adjusts pt to $209 from $212, maintains outperform rating
© MarketScreener.com 2021